| Julu Wagle, | |
|
10900 W 44th Ave Unit 200, Wheat Ridge, CO 80033 | |
| (303) 993-1330 | |
| (303) 284-4082 |
| Full Name | Julu Wagle |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 10900 W 44th Ave Unit 200, Wheat Ridge, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184161473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 1634801 (Colorado) | Secondary |
| 363L00000X | Nurse Practitioner | APN.0994646-NP (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physician Housecalls Llc | 0840212809 | 70 |
News Archive
Strong painkillers known as prescription opioids appear to be overprescribed in some regions of British Columbia (B.C.), resulting in higher rates of overdose and death, according to a new study from UBC.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
New research says breastfeeding does not protect children against developing asthma or allergies.
› Verified 9 days ago
| Entity Name | Physician Housecalls Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295789824 PECOS PAC ID: 0840212809 Enrollment ID: O20051219001031 |
News Archive
Strong painkillers known as prescription opioids appear to be overprescribed in some regions of British Columbia (B.C.), resulting in higher rates of overdose and death, according to a new study from UBC.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
New research says breastfeeding does not protect children against developing asthma or allergies.
› Verified 9 days ago
| Entity Name | Pro Health One Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053714584 PECOS PAC ID: 2466778089 Enrollment ID: O20171120000890 |
News Archive
Strong painkillers known as prescription opioids appear to be overprescribed in some regions of British Columbia (B.C.), resulting in higher rates of overdose and death, according to a new study from UBC.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
New research says breastfeeding does not protect children against developing asthma or allergies.
› Verified 9 days ago
| Entity Name | Forte Health And Wellness Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447888797 PECOS PAC ID: 1456782697 Enrollment ID: O20200504001029 |
News Archive
Strong painkillers known as prescription opioids appear to be overprescribed in some regions of British Columbia (B.C.), resulting in higher rates of overdose and death, according to a new study from UBC.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
New research says breastfeeding does not protect children against developing asthma or allergies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julu Wagle, 10900 W 44th Ave Unit 200, Wheat Ridge, CO 80033-2742 Ph: (303) 993-1330 | Julu Wagle, 10900 W 44th Ave Unit 200, Wheat Ridge, CO 80033 Ph: (303) 993-1330 |
News Archive
Strong painkillers known as prescription opioids appear to be overprescribed in some regions of British Columbia (B.C.), resulting in higher rates of overdose and death, according to a new study from UBC.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
New research says breastfeeding does not protect children against developing asthma or allergies.
› Verified 9 days ago
Mrs. Jennifer M Knodle, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10900 W 44th Ave Unit 200, Wheat Ridge, CO 80033 Phone: 303-379-9371 Fax: 303-284-4082 | |
Katherine Elizabeth Slone, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7495 W 29th Ave, Wheat Ridge, CO 80033 Phone: 303-360-6276 | |
Elizabeth Yan, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3555 Lutheran Pkwy Ste 200, Wheat Ridge, CO 80033 Phone: 720-284-3700 | |
Mrs. Annelle Marie Fahlsing, RNC,NNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8300 W 38th Ave, Wheat Ridge, CO 80033 Phone: 303-425-2217 | |
Kelly Chasin, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3555 Lutheran Pkwy Ste 340, Wheat Ridge, CO 80033 Phone: 303-996-6005 | |
Emily Clare Kubovic, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10900 W 44th Ave Unit 200, Wheat Ridge, CO 80033 Phone: 303-993-1330 Fax: 303-957-5757 | |
Alison Suzanne Burton, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3885 Upham St Ste 100, Wheat Ridge, CO 80033 Phone: 707-266-4970 |